Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cartesian Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 86 | 95 | +9 |
| Shares | 55.6M | 46.8M | −8.86M (−15.9%) |
| Value | $62.8M | $65.1M | +$2.26M (+3.6%) |
New holders (24)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (15)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Mangrove Partners | 5,260,419 | $5.94M |
| Ally Bridge Group (NY) LLC | 2,558,474 | $2.89M |
| BVF Inc | 1,391,749 | $1.57M |
| Rubric Capital Management LP | 721,245 | $815.0K |
| Bank of Montreal | 232,300 | $262.5K |
| XTX Topco Ltd | 186,774 | $211.1K |
| Franklin Resources Inc | 60,923 | $68.8K |
| Connor, Clark & Lunn Investment Management Ltd. | 27,239 | $30.8K |
| Eqis Capital Management, Inc. | 21,225 | $24.0K |
| Belvedere Trading LLC | 20,688 | $23.4K |
| Beacon Pointe Advisors, LLC | 19,000 | $21.5K |
| Advisory Services Network, LLC | 6,000 | $6.78K |
| Ellevest, Inc. | 68 | $77 |
| IFP Advisors, Inc | 45,760 | – |
| Sofos Investments, Inc. | 1 | – |